This Week in Sleep Medicine: December 17, 2019
While You Were Sleeping: What Sleep Technologists Need to Know This Week
🌟 Note: While You Were Sleeping will take a brief holiday hiatus,
returning on Tuesday, January 7, 2020. Have a wonderful holiday season! 🌟
Your media watchdog for headlines and trends
relevant to sleep technology and patient education.
Vanda Pharmaceuticals President Gets Award for Work To Prevent Dog Testing
December 13, 2019
From the article: “Vanda is currently suing the US Food and Drug Administration (FDA) for not allowing its drug to be studied in long-term clinical trials without a dog study. …'There is no evidence that long-term studies on dogs add any predictive value to human safety,' [Vanda Pharmaceuticals president and CEO Mihael Polymeropoulos MD] says in a release. 'The FDA is ignoring a large body of published scientific evidence that concludes these dog studies are uninformative. It is time to demand that the pharmaceutical industry and government regulators abandon unscientific, low-resolution animal testing and adopt modern, human-based scientific methods to advance human drug safety.'”
Takeaway: While sleep science historically owes a debt of gratitude to all the puppies with narcolepsy which previously helped early sleep medicine researchers to better understand central disorders of hypersomnia, times have changed and the industry wants to see the FDA change its protocols accordingly. What do you think?
Sleep Study in Antarctica Explores Role of Cultural Differences
December 1, 2019
From the article: “The harsh conditions and remoteness of the white continent make it one of the best space analogs on Earth, and its extreme seasonal changes make it an ideal setting to study sleep behavior in the absence of regular light patterns. The sun never sets from late October to mid-February, while there is no sunlight at all during the Antarctic winter from late April to mid-August.”
Takeaway: If I were a circadian rhythm researcher, I'd want to study sleep in the South Pole!